Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 5, 2005, Pages 549-556

  Saarikoski, Sirkku T ^a,b   Wikman, Harriet A L ^a,d   Smith, Gillian ^c   Wolff, C Henrik J ^a,d   Husgafvel Pursiainen, Kirsti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cellular expression; CYP2S1; Cytochrome P450; Human cancer; Immunohistochemistry; In situ hybridization; Xenobiotic metabolism

Indexed keywords

AROMATIC HYDROCARBON; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 2S1; DIOXIN; MESSENGER RNA; RETINOIC ACID; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADRENAL GLAND; ARTICLE; BIOTRANSFORMATION; BLADDER; BRONCHIOLE; BRONCHUS; CELL TYPE; CELLULAR DISTRIBUTION; ENZYME LOCALIZATION; EXOCRINE GLAND; EXPOSURE; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ALVEOLUS EPITHELIUM; MALE; METABOLISM; NOSE CAVITY; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RESPIRATORY SYSTEM; SKIN; STEM CELL; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR GROWTH; UTERINE CERVIX;

CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOPLASMS; ORGAN SPECIFICITY; OXYGENASES;

BRONCHUS;

EID: 17844390622     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4C6576.2005     Document Type: Article

References (28)

1. Arpiainen S, Pelkonen O, Hakkola J (2004) Regulation of the mouse cytochrome P450 2A5 gene involves an aryl hydrocarbon receptor dependent pathway. Toxicol Appl Pharmacol 197:368-369
2. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91-100
3. Dey A, Jones JE, Nebert DW (1999) Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem Pharmacol 58:525-537
4. Ding X, Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173
5. Hoffman SM, Nelson DR, Keeney DS (2001) Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics 11:687-698
6. Hukkanen J, Hakkola J, Anttila S, Piipari R, Karjalainen A, Pelkonen O, Raunio H (1997) Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol Carcinog 20:224-230
7. Hukkanen J, Pelkonen O, Hakkola J, Raunio H (2002) Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 32:391-411
8. Ingelman-Sundberg M (2004) Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn-Schmiedeberg's Arch Pharmacol 369:89-104
9. Karlgren M, Miura S, Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol in press
10. Lewis DF (2004) 57 Varieties: the human cytochromes P450. Pharmacogenomics 5:305-318
11. Marill J, Idres N, Capron CC, Nguyen E, Chabot GG (2003) Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab 4:1-10
12. Murray GI (2000) The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol 192:419-426
13. Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, Kadlubar FF (2001) In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 49:229-236
14. Nebert DW (1991) Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203-1214
15. Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162
16. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T (2003) Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369-375
17. Oyama T, Kagawa N, Kunugita N, Kitagawa K, Ogawa M, Yamaguchi T, Suzuki R, et al. (2004) Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci 9:1967-1976
18. Otto DM, Henderson CJ, Carrie D, Davey M, Gundersen TE, Blomhoff R, Adams RH, et al. (2003) Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol Cell Biol 23:6103-6116
19. Pelkonen O, Raunio H (1997) Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Environ Health Perspect 105:767-774
20. Rivera SP, Saarikoski ST, Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255-259
21. Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529-535
22. Saarikoski ST, Husgafvel-Pursiainen K, Hirvonen A, Vainio H, Gonzalez FJ, Anttila S (1998) Localization of CYP1A1 mRNA in human lung by in situ hybridization: comparison with immunohistochemical findings. Int J Cancer 77:33-39
23. Saarikoski ST, Suitiala T, Holmila R, Impivaara O, Järvisalo J, Hirvonen A, Husgafvel-Pursiainen K (2004) Identification of genetic polymorphism of CYP2S1 in a Finnish Caucasian population. Mutat Res 554:267-277
24. Shimada T, Fujii-Kuriyama Y (2004) Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95:1-6
25. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, et al. (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343
26. Stoilov I, Jansson I, Sarfarazi M, Schenkman JB (2001) Roles of cytochrome P450 in development. Drug Metabol Drug Interact 18:33-55
27. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosarnino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074-5079
28. Wikman H, Seppanen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, et al. (2004) Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 203:584-593